{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20120327",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "32172",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202088s002ltr.pdf",
              "date": "20120330",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20120327",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20140218",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20130611",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "9952",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202088Orig1s005ltr.pdf",
              "date": "20130612",
              "type": "Letter"
            },
            {
              "id": "19055",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202088s005lbl.pdf",
              "date": "20130618",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20111013",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "9950",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202088s001ltr.pdf",
              "date": "20111017",
              "type": "Letter"
            },
            {
              "id": "19054",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202088s001lbl.pdf",
              "date": "20111020",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20110613",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "40111",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202088s000_2lbl.pdf",
              "date": "20120328",
              "type": "Label"
            },
            {
              "id": "44842",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202088Origs1s000SumR.pdf",
              "date": "20120309",
              "type": "Summary Review"
            },
            {
              "id": "19053",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202088s000lbl.pdf",
              "date": "20110616",
              "type": "Label"
            },
            {
              "id": "22869",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202088_suprenza_toc.html",
              "date": "20120309",
              "type": "Review"
            },
            {
              "id": "22870",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202088_suprenza_toc.html",
              "date": "20130524",
              "type": "Review"
            },
            {
              "id": "24405",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202088Orig2s000SumR.pdf",
              "date": "20130524",
              "type": "Summary Review"
            },
            {
              "id": "32170",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202088s000ltr.pdf",
              "date": "20110616",
              "type": "Letter"
            },
            {
              "id": "32171",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202088s000ltr.pdf",
              "date": "20120329",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20130711",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "40113",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202088Orig1s006lbl.pdf",
              "date": "20131120",
              "type": "Label"
            },
            {
              "id": "9953",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202088Orig1s006ltr.pdf",
              "date": "20131017",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20121205",
          "review_priority": "901 REQUIRED",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "40112",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202088s004lbl.pdf",
              "date": "20121207",
              "type": "Label"
            },
            {
              "id": "9951",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202088Orig1s004ltr.pdf",
              "date": "20121211",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA202088",
      "sponsor_name": "CITIUS PHARMS",
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "SUPRENZA",
          "active_ingredients": [
            {
              "name": "PHENTERMINE HYDROCHLORIDE",
              "strength": "30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, ORALLY DISINTEGRATING",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "SUPRENZA",
          "active_ingredients": [
            {
              "name": "PHENTERMINE HYDROCHLORIDE",
              "strength": "37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, ORALLY DISINTEGRATING",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "SUPRENZA",
          "active_ingredients": [
            {
              "name": "PHENTERMINE HYDROCHLORIDE",
              "strength": "15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, ORALLY DISINTEGRATING",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}